LSE Equity Snapshot

OBI Weekly Equity Report

Ondine Biomedical Inc.

Interactive chart JSON snapshot
Latest Close 13.00 GBP 12 Jun 2026
1W Return -1.9% latest completed week
4W Return -13.3% short-term follow-through
12W Return 20.9% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
Company Brief

What the company does

Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its primary product is Steriwave, which enables rapid elimination of pathogens associated with healthcare-associated infections. In addition, the company offers a pipeline of products for various indications, including burns, ventilator tube, and sinus; and serious and chronic wounds, chronic sinusitis, ventilator-associated pneumonia VAP, and central line bloodstream infections, as well as catheter-associated urinary tract infection. Ondine Biomedical Inc. was incorporated in 1996 and is headquartered in Vancouver, Canada.

Snapshot

What the weekly tape is saying

OBI closed the latest completed week at 13.00 GBP. The 4-week return is -13.3% and the 12-week return is 20.9%. Trend Signal is active, Market Dynamics is 1.16. Setup signature: Risk-first tape with a 39/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 18.9%
Volume 0.9x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 44 Persistence of active Trend Signal over the last year and current streak.
Momentum 38 Blend of 4-week and 12-week follow-through.
Dynamics 69 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 38 Relative leadership and short-term RS change.
Volume 40 Participation compared with the 13-week volume baseline.
Risk Control 5 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
10.93 GBP
Vs Trend Line
18.9%
Fair Value
10.31 GBP
Vs Fair Value
26.1%
52W High
18.50 GBP
52W Low
7.50 GBP
Drawdown
-29.7%
Range Position
50.0%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -1.9%
4W -13.3%
12W 20.9%
26W 26.8%
52W 23.8%

Trend read

Active Streak
5 weeks
52W Active Weeks
25
52W Active Breadth
48.1%
Sector Scope
GB Healthcare
Sector Rank
43 of 78
Sector Percentile
45.5%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
1.16
4W MD Change
-17.5%
Relative Strength
-1.16
4W RS Change
-106.0%
Expectation
Negative
Probability
29.98%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
2.2M
13W Average
2.3M
52W Average
1.5M
Vs 13W
0.9x
Vs 52W
1.4x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
7.3%
52W Volatility
8.4%
Upside Weeks
18
Downside Weeks
25
Downside Breadth
48.1%
Avg Gain / Loss
8.6% / -4.7%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
LSE
Country
GB
Sector
Healthcare
Industry
Biotechnology
Currency
GBP
Market Cap
77.9M

Opportunity signals

  • Trend Signal is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 13.00 GBP -1.9% 10.93 GBP 10.31 GBP 1.16 -1.16 2.2M On
5 Jun 2026 13.25 GBP -11.7% 10.89 GBP 10.33 GBP 1.38 1.83 3.6M On
29 May 2026 15.00 GBP 0.0% 10.86 GBP 10.34 GBP 1.41 15.28 1.2M On
22 May 2026 15.00 GBP 0.0% 10.80 GBP 10.34 GBP 1.43 15.49 1.3M On
15 May 2026 15.00 GBP 7.1% 10.72 GBP 10.35 GBP 1.41 19.41 3.2M On
8 May 2026 14.00 GBP 19.1% 10.63 GBP 10.36 GBP 1.34 11.95 2.5M Off
1 May 2026 11.75 GBP -6.0% 10.62 GBP 10.39 GBP 1.22 -6.76 4.3M Off
24 Apr 2026 12.50 GBP 8.7% 10.69 GBP 10.43 GBP 1.10 -0.82 1.7M Off
17 Apr 2026 11.50 GBP 4.5% 10.76 GBP 10.48 GBP 1.09 -11.07 3.8M Off
10 Apr 2026 11.00 GBP 4.8% 10.88 GBP 10.52 GBP 1.03 -14.46 1.3M Off
3 Apr 2026 10.50 GBP -2.3% 11.02 GBP 10.56 GBP 0.98 -17.22 1.4M Off
27 Mar 2026 10.75 GBP 0.0% 11.18 GBP 10.59 GBP 0.82 -11.46 1.8M Off
20 Mar 2026 10.75 GBP -2.3% 11.32 GBP 10.62 GBP 0.60 -11.17 1.8M Off
13 Mar 2026 11.00 GBP 7.3% 11.51 GBP 10.67 GBP 0.30 -12.29 923.4K Off